Aethlon Medical, Inc. (AEMD)
How AEMD actually reacts to news — the realized, point-in-time move the market made, measured across 216 labeled events over the last three years with zero look-ahead.
AEMD’s median reaction, across the day.
Half of all Aethlon Medical, Inc. news events land between -3.26% and +1.75% at 30 minutes.
Reaction stats as of 2026-08-18. Reaction = percent move vs. the price at the news timestamp.
Email me when AEMD moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AEMD’s baseline. Nothing else.
Get “How AEMD reacts to news” as a PDF.
A free one-page summary: AEMD’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent AEMD events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program | Press release | PR Newswire | -0.32% | -3.41% | |
| Form 10-Q AETHLON MEDICAL INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.32% | -3.41% | |
| Form 8-K AETHLON MEDICAL INC For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -0.32% | -3.41% | |
| Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 | Press release | PR Newswire | +2.13% | -7.67% | |
| Form 8-K AETHLON MEDICAL INC For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +12.95% | +24.35% | |
| Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® | Press release | PR Newswire | +0.97% | -3.04% | |
| Form 8-K AETHLON MEDICAL INC For: Jul 06 | SEC filing · Form 8-K | SEC EDGAR | -1.83% | -5.19% | |
| Form EFFECT AETHLON MEDICAL INC | SEC filing · Form EFFECT | SEC EDGAR | -6.96% | -7.63% | |
| Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules | Press release | PR Newswire | -2.04% | +17.91% | |
| Form S-1/A AETHLON MEDICAL INC | SEC filing · Form S-1 | SEC EDGAR | -3.34% | +4.28% | |
| Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier® | Press release | PR Newswire | -3.46% | -1.89% | |
| Form S-1 AETHLON MEDICAL INC | SEC filing · Form S-1 | SEC EDGAR | -4.62% | -20.23% | |
| Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update | Press release | PR Newswire | +2.18% | -1.55% | |
| Form 10-K AETHLON MEDICAL INC For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +2.18% | -1.55% | |
| Form 8-K AETHLON MEDICAL INC For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +2.18% | -1.55% | |
| Form S-8 AETHLON MEDICAL INC | SEC filing · Form S-8 | SEC EDGAR | +2.18% | -1.55% | |
| Form 8-K AETHLON MEDICAL INC For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.90% | |
| Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 | Press release | PR Newswire | -0.87% | -3.49% | |
| Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness | Press release | PR Newswire | +0.97% | +1.45% | |
| Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review | Press release | PR Newswire | -1.11% | -4.42% | |
| Form 8-K AETHLON MEDICAL INC For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +1.92% | +6.73% | |
| Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities | Press release | PR Newswire | +1.41% | -1.71% | |
| Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th | Press release | GlobeNewswire | -2.25% | -4.49% | |
| Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 | Press release | PR Newswire | +4.36% | +1.53% | |
| Form 8-K AETHLON MEDICAL INC For: Feb 19 | SEC filing · Form 8-K | SEC EDGAR | +1.04% | +4.43% | |
| Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update | Press release | PR Newswire | -5.23% | +0.00% | |
| Form 10-Q AETHLON MEDICAL INC For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -5.23% | +0.00% | |
| Form 8-K AETHLON MEDICAL INC For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | -5.23% | +0.00% | |
| Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 | Press release | PR Newswire | -1.25% | -6.67% | |
| Form DEFA14A AETHLON MEDICAL INC | SEC filing · Form DEFA14A | SEC EDGAR | — | -6.03% | |
| Form 8-K AETHLON MEDICAL INC For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | -2.29% | -8.20% | |
| Form EFFECT AETHLON MEDICAL INC | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -4.25% | |
| Form DEF 14A AETHLON MEDICAL INC For: Feb 19 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -4.25% | |
| Form S-1 AETHLON MEDICAL INC | SEC filing · Form S-1 | SEC EDGAR | +2.26% | -7.52% | |
| Form EFFECT AETHLON MEDICAL INC | SEC filing · Form EFFECT | SEC EDGAR | +1.09% | +0.00% | |
| Form D AETHLON MEDICAL INC | SEC filing · Form D | SEC EDGAR | — | -6.99% | |
| Form S-3 AETHLON MEDICAL INC | SEC filing · Form S-3 | SEC EDGAR | -2.08% | -7.96% | |
| Form 8-K AETHLON MEDICAL INC For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +5.35% | |
| Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million | Press release | PR Newswire | +1.92% | +1.37% | |
| Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs | Press release | PR Newswire | — | +14.60% | |
| Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update | Press release | PR Newswire | +3.97% | — | |
| Form 10-Q AETHLON MEDICAL INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.97% | — | |
| Form 8-K AETHLON MEDICAL INC For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +3.97% | — | |
| Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 | Press release | PR Newswire | +0.48% | -0.24% | |
| Form 8-K AETHLON MEDICAL INC For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | +0.23% | -4.05% | |
| Form 8-K AETHLON MEDICAL INC For: Oct 22 | SEC filing · Form 8-K | SEC EDGAR | +0.80% | +8.04% | |
| Form 8-K AETHLON MEDICAL INC For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | +2.31% | -15.00% | |
| Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial | Press release | PR Newswire | +2.31% | -5.65% | |
| Form 8-K AETHLON MEDICAL INC For: Sep 12 | SEC filing · Form 8-K | SEC EDGAR | +0.63% | -2.52% | |
| Form 8-K AETHLON MEDICAL INC For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | +4.60% | +3.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AEMD section they belong to.
More of the dataset.
AEMD earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Aethlon Medical, Inc.'s median reaction calculated?
Every labeled AEMD news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 216 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of AEMD's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-18.
Does AEMD's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.